EE

Endovascular Engineering

Menlo Park, United States · $122.0M raised

Headquarters
Menlo Park
Business Model
B2B
Total Funding
$122.0M
Last Round
$80.0M Series CApr 2026
Rounds
2

About

Endovascular Engineering, Inc. ("E2") is a venture-backed medical device company based in Menlo Park, California, developing minimally invasive mechanical thrombectomy systems for treating venous thromboembolism (VTE), including its Hēlo aspiration system evaluated in the ENGULF pivotal study for pulmonary embolism. The company raised an oversubscribed $80M Series C led by Gilde Healthcare and Norwest Venture Partners, and is led by CEO Dan Rose.

Summary

Endovascular Engineering is a Healthcare company based in Menlo Park, United States. It has raised $122.0M in total across 2 rounds, most recently a $80.0M Series C round in Apr 2026. Investors include 415 Investments, S3 Ventures and Gilde Healthcare.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CApr 2026
$80.0M

Sign up to see all 2 rounds

Series B through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Endovascular Engineering on Indexed.vc
<a href="https://indexed.vc/companies/endovascular-engineering"><img src="https://indexed.vc/api/badge/company/endovascular-engineering" alt="Endovascular Engineering on Indexed.vc" width="260" height="76" /></a>